Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/138551
Title: Drug-free microneedles in the treatment of keloids : a single-blinded intraindividual controlled clinical trial
Authors: Tan, Collin W X
Yeo, David Chen Long
Cao, Taige
Tan, Wei Ding V
Srivastava, Ruchir
Yow, Ai Ping
Tan, Wee Ping
Wong, Damon Wing Kee
Xu, Chenjie
Tey, Hong Liang
Keywords: Engineering::Chemical engineering
Issue Date: 2018
Source: Tan, C. W. X., Yeo, D. C. L., Cao, T., Tan, W. D. V., Srivastava, R., Yow, A. P., . . . Tey, H. L. (2018). Drug-free microneedles in the treatment of keloids : a single-blinded intraindividual controlled clinical trial. British Journal of Dermatology, 179(6), 1418-1419. doi:10.1111/bjd.17078
Journal: British Journal of Dermatology
Abstract: Keloids are a common skin disorder with significant morbidity. Itch and pain are common symptoms that affect up to 80% of patients. First-line treatment is repeated intralesional corticosteroid injections, which are painful and prone to recurrence of lesions. In a previous study, we observed that solid microneedles exhibited contact-dependent inhibition on cultured keloid and normal skin fibroblasts, in the absence of drugs.
URI: https://hdl.handle.net/10356/138551
ISSN: 0007-0963
DOI: 10.1111/bjd.17078
Rights: © 2018 British Association of Dermatologists. All rights reserved. This paper was published in British Journal of Dermatology and is made available with permission of British Association of Dermatologists.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
Drug-free microneedles in the treatment of keloids.pdf98.96 kBAdobe PDFView/Open

WEB OF SCIENCETM
Citations 50

2
checked on Oct 18, 2020

Page view(s) 50

25
checked on Oct 20, 2020

Download(s) 50

5
checked on Oct 20, 2020

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.